EVOFEM BIOSCIENCES, INC. Proceeds from Short-term Debt
EVOFEM BIOSCIENCES, INC. (EVFM) reported Proceeds from Short-term Debt of $1.07 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromShortTermDebt · last filed 2026-08-14
- EVOFEM BIOSCIENCES, INC. proceeds from short-term debt for the quarter ending 2025-12-31 was $0.00.
- EVOFEM BIOSCIENCES, INC. proceeds from short-term debt for the quarter ending 2025-09-30 was $0.00.
- EVOFEM BIOSCIENCES, INC. proceeds from short-term debt for the quarter ending 2024-12-31 was $0.00.
- EVOFEM BIOSCIENCES, INC. proceeds from short-term debt for the quarter ending 2024-09-30 was $0.00.
- EVOFEM BIOSCIENCES, INC. proceeds from short-term debt for fiscal 2025 was $383.00K, a 3.53% decline from fiscal 2024.
- EVOFEM BIOSCIENCES, INC. proceeds from short-term debt for fiscal 2024 was $397.00K, a 92.96% decline from fiscal 2023.
- EVOFEM BIOSCIENCES, INC. proceeds from short-term debt for fiscal 2023 was $5.64M.
| Period end | Proceeds from Short-term Debt 3 month | Proceeds from Short-term Debt 6 month | Proceeds from Short-term Debt 9 month | Proceeds from Short-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.07M 10-Q · filed 2026-08-14 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $0.00 derived: sum of 2 quarters · filed 2026-03-11 | $383.00K 10-K · filed 2026-03-11 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $383.00K 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $383.00K 10-Q · filed 2026-08-14 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $0.00 derived: sum of 2 quarters · filed 2026-03-11 | $397.00K 10-K · filed 2026-03-11 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $397.00K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $397.00K 10-Q · filed 2025-08-14 | |||
| 2023-12-31 | $5.64M 10-K · filed 2025-03-24 |